Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma

Francesca Rappa, Azzura Greco, Christine Podrini, Francesco Cappello, Michelangelo Foti, Lucie Bourgoin, Marion Peyrou, Arianna Marino, Nunzia Scibetta, Roger Williams, Gianluigi Mazzoccoli, Massimo Federici, Valerio Pazienza, Manlio Vinciguerra

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in the liver, defined as hepatosteatosis, is an independent and strong risk factor for developing an HCC. MacroH2A1, a histone protein generally associated with the repressed regions of chromosomes, is involved in hepatic lipid metabolism and is present in two alternative spliced isoforms, macroH2A1.1 and macroH2A1.2. These isoforms have been shown to predict lung and colon cancer recurrence but to our knowledge, their role in fatty-liver associated HCC has not been investigated previously. Methods: We examined macroH2A1.1 and macroH2A1.2 protein expression levels in the liver of two murine models of fat-associated HCC, the high fat diet/diethylnistrosamine (DEN) and the phosphatase and tensin homolog (PTEN) liver specific knock-out (KO) mouse, and in human liver samples of subjects with steatosis or HCC, using immunoblotting and immunohistochemistry. Results: Protein levels for both macroH2A1 isoforms were massively upregulated in HCC, whereas macroH2A1.2 was specifically upregulated in steatosis. In addition, examination of human liver samples showed a significant difference (p

Original languageEnglish
Article numbere54458
JournalPLoS One
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 29 2013

Fingerprint

hepatoma
histones
Liver
Histones
Hepatocellular Carcinoma
Protein Isoforms
liver
Fats
Proteins
Biomarkers
Chromosomes
Nutrition
Phosphoric Monoester Hydrolases
early diagnosis
risk reduction
fatty liver
High Fat Diet
Fatty Liver
Risk Reduction Behavior
lung neoplasms

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Rappa, F., Greco, A., Podrini, C., Cappello, F., Foti, M., Bourgoin, L., ... Vinciguerra, M. (2013). Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma. PLoS One, 8(1), [e54458]. https://doi.org/10.1371/journal.pone.0054458

Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma. / Rappa, Francesca; Greco, Azzura; Podrini, Christine; Cappello, Francesco; Foti, Michelangelo; Bourgoin, Lucie; Peyrou, Marion; Marino, Arianna; Scibetta, Nunzia; Williams, Roger; Mazzoccoli, Gianluigi; Federici, Massimo; Pazienza, Valerio; Vinciguerra, Manlio.

In: PLoS One, Vol. 8, No. 1, e54458, 29.01.2013.

Research output: Contribution to journalArticle

Rappa, F, Greco, A, Podrini, C, Cappello, F, Foti, M, Bourgoin, L, Peyrou, M, Marino, A, Scibetta, N, Williams, R, Mazzoccoli, G, Federici, M, Pazienza, V & Vinciguerra, M 2013, 'Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma', PLoS One, vol. 8, no. 1, e54458. https://doi.org/10.1371/journal.pone.0054458
Rappa, Francesca ; Greco, Azzura ; Podrini, Christine ; Cappello, Francesco ; Foti, Michelangelo ; Bourgoin, Lucie ; Peyrou, Marion ; Marino, Arianna ; Scibetta, Nunzia ; Williams, Roger ; Mazzoccoli, Gianluigi ; Federici, Massimo ; Pazienza, Valerio ; Vinciguerra, Manlio. / Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma. In: PLoS One. 2013 ; Vol. 8, No. 1.
@article{0c40e688f8134750a8f7eec7d7bdd34f,
title = "Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma",
abstract = "Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in the liver, defined as hepatosteatosis, is an independent and strong risk factor for developing an HCC. MacroH2A1, a histone protein generally associated with the repressed regions of chromosomes, is involved in hepatic lipid metabolism and is present in two alternative spliced isoforms, macroH2A1.1 and macroH2A1.2. These isoforms have been shown to predict lung and colon cancer recurrence but to our knowledge, their role in fatty-liver associated HCC has not been investigated previously. Methods: We examined macroH2A1.1 and macroH2A1.2 protein expression levels in the liver of two murine models of fat-associated HCC, the high fat diet/diethylnistrosamine (DEN) and the phosphatase and tensin homolog (PTEN) liver specific knock-out (KO) mouse, and in human liver samples of subjects with steatosis or HCC, using immunoblotting and immunohistochemistry. Results: Protein levels for both macroH2A1 isoforms were massively upregulated in HCC, whereas macroH2A1.2 was specifically upregulated in steatosis. In addition, examination of human liver samples showed a significant difference (p",
author = "Francesca Rappa and Azzura Greco and Christine Podrini and Francesco Cappello and Michelangelo Foti and Lucie Bourgoin and Marion Peyrou and Arianna Marino and Nunzia Scibetta and Roger Williams and Gianluigi Mazzoccoli and Massimo Federici and Valerio Pazienza and Manlio Vinciguerra",
year = "2013",
month = "1",
day = "29",
doi = "10.1371/journal.pone.0054458",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma

AU - Rappa, Francesca

AU - Greco, Azzura

AU - Podrini, Christine

AU - Cappello, Francesco

AU - Foti, Michelangelo

AU - Bourgoin, Lucie

AU - Peyrou, Marion

AU - Marino, Arianna

AU - Scibetta, Nunzia

AU - Williams, Roger

AU - Mazzoccoli, Gianluigi

AU - Federici, Massimo

AU - Pazienza, Valerio

AU - Vinciguerra, Manlio

PY - 2013/1/29

Y1 - 2013/1/29

N2 - Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in the liver, defined as hepatosteatosis, is an independent and strong risk factor for developing an HCC. MacroH2A1, a histone protein generally associated with the repressed regions of chromosomes, is involved in hepatic lipid metabolism and is present in two alternative spliced isoforms, macroH2A1.1 and macroH2A1.2. These isoforms have been shown to predict lung and colon cancer recurrence but to our knowledge, their role in fatty-liver associated HCC has not been investigated previously. Methods: We examined macroH2A1.1 and macroH2A1.2 protein expression levels in the liver of two murine models of fat-associated HCC, the high fat diet/diethylnistrosamine (DEN) and the phosphatase and tensin homolog (PTEN) liver specific knock-out (KO) mouse, and in human liver samples of subjects with steatosis or HCC, using immunoblotting and immunohistochemistry. Results: Protein levels for both macroH2A1 isoforms were massively upregulated in HCC, whereas macroH2A1.2 was specifically upregulated in steatosis. In addition, examination of human liver samples showed a significant difference (p

AB - Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in the liver, defined as hepatosteatosis, is an independent and strong risk factor for developing an HCC. MacroH2A1, a histone protein generally associated with the repressed regions of chromosomes, is involved in hepatic lipid metabolism and is present in two alternative spliced isoforms, macroH2A1.1 and macroH2A1.2. These isoforms have been shown to predict lung and colon cancer recurrence but to our knowledge, their role in fatty-liver associated HCC has not been investigated previously. Methods: We examined macroH2A1.1 and macroH2A1.2 protein expression levels in the liver of two murine models of fat-associated HCC, the high fat diet/diethylnistrosamine (DEN) and the phosphatase and tensin homolog (PTEN) liver specific knock-out (KO) mouse, and in human liver samples of subjects with steatosis or HCC, using immunoblotting and immunohistochemistry. Results: Protein levels for both macroH2A1 isoforms were massively upregulated in HCC, whereas macroH2A1.2 was specifically upregulated in steatosis. In addition, examination of human liver samples showed a significant difference (p

UR - http://www.scopus.com/inward/record.url?scp=84872808889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872808889&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0054458

DO - 10.1371/journal.pone.0054458

M3 - Article

C2 - 23372727

AN - SCOPUS:84872808889

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e54458

ER -